- Directors and Auditors
- Articles of Association
- General Meetings
- - Previous General Meetings
- Insider Trading
Dignitana AB appoints Chief Financial Officer
Dignitana AB announces Ulf Jönsson has been appointed Chief Financial Officer, effective 1 July 2022.
Ulf has over 20 years of finance experience in multiple sectors including healthcare, technology and manufacturing. He is currently Interim Group Operations Controller for Diab International AB and was previously CFO for MalmbergGruppen, an environmental tech company. He spent 10 years with global med tech Gambro AB as Controller and then Director of Finance prior to the Company’s 2013 acquisition by Baxter.
“Ulf brings to Dignitana diverse financial expertise and significant work in global finance and business performance,” said Klas Arildsson, Dignitana Chairman of the Board. “As the Company continues an extended growth trajectory, Ulf’ s ability to create value will ensure that we maintain a solid financial foundation as we move toward cash flow positivity.”
Ulf Jönsson stated, “I see a very strong future and growth potential for Dignitana. It is an exciting time with building awareness and patient access from reimbursement. I am eager to begin supporting that work as we advance to the next level.”
Sweden-based Dignitana is the world leader in scalp cooling innovation and the DigniCap Scalp Cooling System is available in 40 countries around the globe.
For More Information Contact
Melissa Bourestom, Chief Communications Officer, email@example.com +1 469-518-5031
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001. Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and US operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB +46 8 121 576 90, firstname.lastname@example.org. Learn more at www.dignitana.com or www.dignicap.com.